Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regorafenib in metastatic solid tumors (RESOUND)
NCT02307500Phase 2Completed
- Sponsor
- Humanitas Research Hospital
- Start
- Dec 2014
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of regorafenib in pancreatic cancer (PC), ovarian cancer, melanoma, sarcoma, thymoma, sponsored by Humanitas Research Hospital. Started Dec 2014; status: completed.
02
Drugs
regorafenib
03
Conditions
pancreatic cancer (PC)ovarian cancermelanomasarcomathymoma
Beyond the preview
Go deeper on NCT02307500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02307500.